Cargando…

Rectal tumor fragmentation as a response pattern following chemoradiation

BACKGROUND: Tumor response to neoadjuvant therapy is heterogenous and prognostically important for locally advanced rectal adenocarcinoma (LARC) patients. Commonly applied response classification approaches including tumor regression grading (TRG) and TN downstaging can be discordant. The aim of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Matthew N., Naz, Afrin, Sanchez, Julian, Dessureault, Sophie, Imanirad, Iman, Lauwers, Gregory, Moore, Michelle, Hoffe, Sarah, Frakes, Jessica, Felder, Seth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830359/ https://www.ncbi.nlm.nih.gov/pubmed/36636056 http://dx.doi.org/10.21037/jgo-22-477

Ejemplares similares

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
por: McDonald, Jordan, et al.
Publicado: (2021)

Phase I Study of Lenvatinib and Capecitabine with External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma
por: Mehta, Rutika, et al.
Publicado: (2022)

Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy
por: Yuan, Zhigang, et al.
Publicado: (2021)

Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma
por: Sinnamon, Andrew J., et al.
Publicado: (2023)

The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census‐tract dataset
por: Dhahri, Amina, et al.
Publicado: (2021)

Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management
por: Tchelebi, Leila T., et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

BRAF Mutations Are Associated with Poor Survival Outcomes in Advanced-stage Mismatch Repair-deficient/Microsatellite High Colorectal Cancer
por: Tan, Elaine, et al.
Publicado: (2022)

Predictors of Complete Response and Disease Recurrence Following Chemoradiation for Rectal Cancer
por: Bitterman, Danielle S., et al.
Publicado: (2015)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer
por: Smithson, Mary, et al.
Publicado: (2022)

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
por: Verstraete, M, et al.
Publicado: (2015)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
por: Lombardi, Raffaele, et al.
Publicado: (2009)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
por: Restivo, Angelo, et al.
Publicado: (2015)

Predictive clinical model of tumor response after chemoradiation in rectal cancer
por: Santos, Marisa D, et al.
Publicado: (2017)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2017)

The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer
por: Palma, Pablo, et al.
Publicado: (2010)

Dosimetric Coverage of the External Anal Sphincter by 3-Dimensional Conformal Fields in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation: Implications for the Concept of Sphincter-Preserving Radiation Therapy
por: Chen, Yi-Jen, et al.
Publicado: (2014)

Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
por: Lee, Yong Joon, et al.
Publicado: (2018)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
por: Ott, Oliver J., et al.
Publicado: (2021)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
por: Dayde, Delphine, et al.
Publicado: (2021)

Optimized tools and timing of response reassessment after neoadjuvant chemoradiation in rectal cancer
por: Chen, Junbing, et al.
Publicado: (2022)

Preoperative MRI accuracy after neoadjuvant chemoradiation for locally advanced rectal cancer
por: Popiţa, Anca-Raluca, et al.
Publicado: (2023)

Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer
por: Jensen, Garrett L., et al.
Publicado: (2023)

Novel MR-Guided Radiotherapy Elective Rotation for Radiation Oncology Trainees
por: Sim, Austin J, et al.
Publicado: (2020)

Impact of the distal resection margin on local recurrence after neoadjuvant chemoradiation and rectal excision for locally advanced rectal cancer
por: Song, Seung Ho, et al.
Publicado: (2021)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
por: Jeong, Duck Hyoun, et al.
Publicado: (2013)

Multimodal Assessments Are Needed for Restaging after Neoadjunvant Chemoradiation Therapy in Rectal Cancer Patients
por: Kye, Bong-Hyeon, et al.
Publicado: (2016)

What the radiologist needs to know about restaging of rectal carcinoma after chemoradiation therapy
por: Nazar, ME, et al.
Publicado: (2014)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
por: Wan, Juefeng, et al.
Publicado: (2015)

17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response
por: Santos, Marisa D., et al.
Publicado: (2015)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

Association of tumor differentiation and prognosis in patients with rectal cancer undergoing neoadjuvant chemoradiation therapy
por: Huang, Qunsheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tflsecbck8u2smciug6bm5ogg4